Alnylam Pharmaceuticals
ALNY
#695
Rank
ยฃ27.20 B
Marketcap
ยฃ203.78
Share price
1.13%
Change (1 day)
-15.67%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company